DrAndyRosenfarb
@drandyrosenfarb • Joined July 13, 2010
At a glance
Subscribers
Last 24 days7.53K
Views
Last 24 days652K
Videos
Last 24 days391
Charts
Subscribers, views & videos over time
Subscribers gained (weekly) · 6 mo
Views gained (weekly) · 6 mo
Subs milestone changes (up to 30)
Views milestone changes (up to 30)
Engagement
Avg. views per video
1.66K
Total views ÷ total videos
Views per subscriber
87×
Total views ÷ subscribers
Subs per video
19
Subscribers ÷ total videos
Revenue estimate
Details →Total (all-time): $457 – $1.30K
Daily avg.: $0 – $1
Weekly avg.: $3 – $10
Last 24 days: $11 – $33
Based on estimated $0.7–$2 CPM.
Analytics tables
Analytics Table:DrAndyRosenfarb
| Date | subscribers | views | videos |
|---|---|---|---|
Jun 22, 2026 Jun 22 Mon | 7.53K +30 | 652K +2.01K | 391 -- |
Jun 15, 2026 Jun 15 Mon | 7.50K +40 | 650K +3.78K | 391 +3 |
Jun 14, 2026 Jun 14 Sun | 7.46K +40 | 646K +5.79K | 388 +2 |
Jun 1, 2026 Jun 1 Mon | 7.42K +40 | 640K +4.82K | 386 +3 |
May 31, 2026 May 31 Sun | 7.38K +110 | 635K +11.2K | 383 +4 |
May 11, 2026 May 11 Mon | 7.27K -- | 624K -- | 379 -- |
Subscribers gained (weekly)
| Week | Subscribers gained | Change vs prev |
|---|---|---|
May 31, 2026 | 110 | +110 |
Jun 1, 2026 | 40 | -70 |
Jun 14, 2026 | 40 | -- |
Jun 15, 2026 | 40 | -- |
Jun 22, 2026 | 30 | -10 |
Views gained (weekly)
| Week | Views gained | Change vs prev |
|---|---|---|
May 31, 2026 | 11.2K | +11.2K |
Jun 1, 2026 | 4.82K | -6.43K |
Jun 14, 2026 | 5.79K | +968 |
Jun 15, 2026 | 3.78K | -2.00K |
Jun 22, 2026 | 2.01K | -1.76K |
About
Dr. Andy Rosenfarb, ND, DTCM, MTOM, L.Ac. rtACA Alternating Current Microcurrent Therapy, Ophthalmic Acupuncture/ Micro Acupuncture 48 & Acu-Laser Photobiomodulation Therapy, Hyperbaric Oxygen Therapy, Red Light Therapy for Macular Degeneration (wet and dry), Retinitis Pigmentosa, Usher Syndrome, Glaucoma, Optic Nerve …
- Handle
- @drandyrosenfarb
- Joined
- July 13, 2010
More features coming
We're working on new analytics and tools. Stay tuned.
More features coming
We're working on new analytics and tools. Stay tuned.